Complete remission of B-cell chronic lymphocytic leukaemia after oral cladribine
- 2 January 1993
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 341 (8836) , 54
- https://doi.org/10.1016/0140-6736(93)92530-7
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Response to 2-Chlorodeoxyadenosine in Patients with B-Cell Chronic Lymphocytic Leukemia Resistant to FludarabineNew England Journal of Medicine, 1992
- On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration.Journal of Clinical Oncology, 1992
- Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.Proceedings of the National Academy of Sciences, 1992
- 2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1991
- Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working groupAmerican Journal of Hematology, 1988
- Synthesis of 2'-deoxytubercidin, 2'-deoxyadenosine, and related 2'-deoxynucleosides via a novel direct stereospecific sodium salt glycosylation procedureJournal of the American Chemical Society, 1984